Hepatocyte growth factor (HGF) secreted from human promyelocytic leukemia cell line, HL-60, is indistinguishable from HGF in human plasma and its release is significantly stimulated by 1 2-0-tetradecanoylphorbol-I 3-acetate (TPA), a differentiation-inducer of HL-60 cells into monocytes/macrophages (Nishino T et al: Biochem Biophys Res Commun 181 :323, 1991). TPA stimulated HGF release from the cells through an activation of C-kinase, but not through a formation of reactive oxygen species. Furthermore, dibutyryl cAMP (dbcAMP), an activator of A-kinase and granulocyte-inducer, also stimulated HGF release. 1 ,SB-Dihydroxyvitamin D3, another monocyte/ macrophage-inducer, abated either TPA-or dbcAMP-stimulated synthesis and release of HGF in a dose-dependent manner probably via its nuclear receptor as reflected by E HAVE RECENTLY reported that human pro-W myelocytic leukemia cells, HL-60, synthesize hepatocyte growth factor (HGF)-like immunoreactivity, which shows identical moieties to human HGF in the plasma of patients with fulminant hepatitis on cation-exchange fast protein liquid chromatography (FPLC), heparin-affinity chromatography, and C, reverse-phase high performance liquid chromatography (HPLC).' Furthermore, both HGF in human plasma and from HL-60 cells are disulfide-linked heterodimers of a heavy subunit of 56 to 60 Kd and of a light subunit of 32 to 34 Kd. 12-0-Tetradecanoylphorbol-13-acetate (TPA), a monocyte/macrophage-inducer, significantly stimulates HGF secretion from HL-60 cells into culture medium in association with a significant increase in the levels of HGF mRNA of 6.0-kb long, which is identical in size to that of human HGF.' HGF, also known as hepatopoietin-A, was originally identified as a factor to stimulate hepatocyte growth and recently purified with its primary structure determined.2" Recently, it has been reported that rat HGF mRNA is expressed in various tissues' and that HGF has a direct effect on a broad spectrum of cell types, such as kidney tubular epithelium,* keratinocytes, endothelial cells, melanocytes,' and sarcoma cells." Furthermore, it was reported that HGF is identical with scatter factor, a fibroblast-secreted protein that promotes motility and matrix invasion of epithelial cells." These data indicated the physiologic significance of HGF in a much broader spectrum of tissues than originally considered.
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In the present study, we investigated the mechanism of regulation of HGF release from HL-60 cells by using TPA, dibutyryl cAMP (dbcAMP), and 1,25-dihydroxyvitamin D, (1 ,25-[OH],D,). Furthermore, we examined whether HGF shows a direct effect of bone cells by using mouse osteoblastic cell line, MC3T3-E1, to examine the possible importance of HGF in the interaction of bone marrow (BM) cells with bone cells.
vitamin D analog study. The effects of these three reagents on the steady-state levels of HGF mRNA of 6.0 kb corresponded with their effects on its protein levels. Furthermore, a close correlation between intracellular and extracellular HGF levels strongly suggested that these reagents affected HGF release mainly on its synthesis step. Recombinant human HGF significantly stimulated the proliferation and alkaline phosphatase activity of mouse osteoblastic cell line, MC3T3-El. In summary, HL-60 cells secrete HGF, whose synthesis is specifically regulated by various reagents independent of their differentiation-inducing effects. Because HGF shows a direct effect on osteoblast-like cells, it might be involved in the interaction of bone marrow cells with bone cells. plemented with 10% heat-inactivated fetal bovine Serum (FBS; GIBCO, Grand Island, NY), in a humidified air at 37°C. Under these conditions, the doubling time was less than 48 hours. Each flask was usually inoculated at 2.0 X IO6 cells/mL. Mouse osteoblastic cell line, MC3T3-EI, was cultured in a-Modification of Eagle's Medium (a-MEM) containing 10% FBS, as previously described." Vitamin D, analogs and TPA dissolved in ethanol, were added so that the final concentration of ethanol was less than 0.1%. Cell number was monitored with a hemacytometer and cell viability determined by trypan blue exclusion.
Preparation qfHL-60 cell extract. HL-60 cells were washed two times with PBS. Cell pellets were suspended in PBS-T and sonicated at level 3 in a continuous mode with three 20-second cycles interrupted by 60-second pause by Branson Sonifier (model 200; Branson, Danbury, USA). The sonicate was centrifuged 27,OOOg for 60 minutes. The supernatant fraction was stored at -30°C until used for the determination of HGF levels by enzyme-linked immunosorbent assay (ELISA).
HGF levels in culture medium and cell extract were determined by using ELISA system as we established previously.'* Briefly, standard human HGF or samples with unknown concentrations of HGF were dispensed into a 96-well microtiter plate coated with a monoclonal antibody (MoAb) against human HGF. After incubation for 1 hour, it was washed three times with PBS-T. After the addition of a 0.1-mL aliquot of a polyclonal antibody against human HGF, the plate was incubated for 1 hour, then washed three times with PBS-T. After the addition of 0.2 mL of diluted goat (antirabbit Ig) IgG-peroxidase conjugate, the plate was incubated for 1 hour and then washed. An aliquot (0.1 mL) of 0.25% 0-phenylenediamine was added and the plate allowed to stand for 10 minutes. After the reaction was stopped by the addition of 0.1 mL of 1 .0-N H2S0,, the absorbance was read at 492 nm by an automatic plate reader with a reference wavelength of 690 nm.
Northern blot analysis. Total cellular RNA was prepared from HL-60 cells with a minor modification of the method previously described.'6 Briefly, after washed twice with PBS, cells (1.4 X IO' cells) were pelleted in a 1.5-mL Eppendorftube (Eppendorf, Hamburg, Germany). Then cells were resuspended in 200 pL of ice-cold TNMN. After vigorous vortexing, cytoplasmic lysates prepared by centrifugation were transferred to fresh microfuge tubes containing 200 pL of TENUS. The solution was extracted with phenol/chloroform. RNA (10 pg/lane) was electrophoresed in 1% agarose gel containing formaldehyde, transferred to a nylon filter, and hybridized at 37°C for 40 hours with [32P]-labeled human HGF cDNA as probes in 50 mmol/L Tris/HCI (pH 7.5) 50% formamide, 3 X SSC, 0. I % SDS, 20 gg/mL tRNA, 20 pg/mL boiled salmon sperm DNA, 1 mmol/L EDTA, 0.028 bovine serum albumin (BSA), 0.2% polyvinylpyrolidone, and 0.02% Ficoll (Pharmacia, Uppsala, Sweden). The filter was washed with 2 X SSC, 15 SDS, 1 X Denhart at 37°C for 1 hour, followed by 0.1 X SCC, I X SDS at 50°C for 1 hour.
For proliferation assay, cells were inoculated at 5 X IO4 cells per 10 cm2 plastic dish. After 24 hours ofcultures in MEM containing 10% FBS, cells were washed three times with MEM and then treated for another 48 hours with HGF ( 1 50 ng/ mL) or vehicle in the medium containing 2% FBS. The [3H]-thymidine (6.7 Ci/mmol) was added at a dosage of 1 pCi/well to the medium for the last 6 hours of the culture period. Then the cells were washed three times with PBS to remove exchangeable radioactivity and then treated with 10% trichloroacetic acid (TCA). TCAinsoluble radioactivity was measured." T o determine the effect of HGF on cellular alkaline phosphatase activity, cells, inoculated at 5.0 X lo4 cells per 10 cm2 dish, were cultured for 4 days in the medium supplemented with 10% FBS. After the confluent cells Determination ofHGFconcentration.
MC3T3-EI crN.
were rested in serum-free medium for 48 hours, they were treated with HGF (150 ng/mL) or vehicle for another 72 hours in MEM containing 2% FBS. Then, the cells were washed three times with PBS and then treated with 1 % Triton X-100 (Wako Pure Biochemical) in PBS for I hour on ice.18 Alkaline phosphatase activity in the cellular extract was measured as described." Protein levels were determined as described.20
RESULTS
The mechanism of TPA.for the stimulation of HGF secretion into culture medium. We have previously reported that HGF secreted from HL-60 cells is identical with human HGF in human plasma.' TPA significantly stimulates HGF release into culture medium in a dose-dependent manner. We examined whether C-kinase is involved in the stimulation of HGF release from HL-60 cells by TPA, which is known to directly stimulate C-kinase. As shown in Fig 1,20 fimol/L H7, a C-kinase inhibitor," inhibited TPA-stimulated HGF release, whereas the same concentration of HA 1004, a IO-fold weaker inhibitor of C-kinase, failed to inhibit HGF release. These data suggested that TPA might stimulate HGF release from HL-60 cells through an activation of C-kinase. When exposed to TPA, HL-60 cells undergo a burst of oxygen metabolism with a resultant formation of reactive oxygen species (ROS),22,23 such as hydrogen peroxide and superoxide. However, 10 pmol/L of potassium superoxide or 50 pmol/L cumene hydroperoxide, enough to stimulate differentiation of Friend erythroleukemia cells,24 did not affect HGF release from HL-60 cells, suggesting that ROS formation might not play an important role in TPA-stimulated HGF release (data not shown). For for the determinations of cell number, cell pellets were suspended in PBS containing 0.05% Tween 20, followed by the sonication with three 20-second cycles interrupted by 60-second pause. After the sonicates were centrifuged at 27,0009 for 60 minutes, the supernatant fractions were collected as cell extract for the determination of intracellular HGF levels. Results are expressed as the mean of t w o cultures.
1,25-(OH),D3 alone did not affect basal HGF release from HL-60 cells. However, 1,25-(OH),D3 inhibited TPA-stimulated HGF release in a dose-dependent manner (Fig 2) . The inhibitory effect of 1,25-(0~),D, was initially detected at 10-10 mol,^ and the effect increased with concentrations up to respectively. on the basis of the concentration of each analog required for 50% inhibition of the TPA-induced stimulation. The biologic potency ratio of each vitamin D3 analog was in good agreement with its reported binding affiniw for 1 , 2 5 -( 0~)~~, receptor. ~~~~l~~ are expressed as the mean f SD of three cultures. *P < .005 versus control.
For personal use only. on November 11, 2017. by guest www.bloodjournal.org From 56 together, it was strongly suggested that I .ZS-(OH)?D, exerts its effect on HGF secretion via nuclear 1 .2S-(OH)zD, recep tor. Next. to determine whether TPA and I .2S-(OH)?D3 affect HGF synthesis and/or its secretory process. HGF levels were determined both in culture medium and in cellular extract. TPA-and/or I .2S-(OH)2D,-induccd changes in intracellular HGF levels corresponded very well to those in extracellular levels (Fig 4) . suggesting that these reagents affected HGF synthesis but not its secretion. Furthermore. the effects of these reagents on HGF release were preceded by their differentiation-inducing effects (data not shown). (Fig 6A) . as we previously reported.' As scmiquantitated by densitometric analysis (Fig 6R) . the levels of HGF transcripts increased significantly around 2.6-and 2. I -fold after 24 hours of exposure toeither 1.0 ng/mL ofTPA or IO-' mol/LdbcAMP, respectively. Treatment of HL-60 cells with a combination of TPA and dbcAMP acted synergistically to increase the levels of HGF transcript around 4.5-fold. The increase induced by either reagent was abated by the simultaneous treatment with IO-' mol/L l.25-(OH)?D3. which is in good agreement with the effects of those reagents on the levels of HGF molecule. Ofsomc interest. the level of HL-60 mRNA
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in cells treated with 1 ,25-(OH),D, alone were significantly lower than in control cells.
Effect of HGF on mouse osteoblastic cell line, MC3T3-E l . It has been recently reported that HGF exerts its effect on various kinds of cells besides hepatocyte, although hepatocyte was originally considered as an only and specific target cell for HGF. Furthermore, because HGF release is specifically regulated by 1,25-(OH),D,, which is known to have its major effect on bone, we examined the possible involvement of HGF in the interaction of BM cells with bone cells. As shown in Fig 7, Statistical signiJicance. Results were expressed as means k SD. Difference between groups were determined by Student's t-test.
DISCUSSION
In the present study, we showed that TPA stimulated HGF release from HL-60 cells through an activation of Ckinase and that I ,25-(OH),D,, another differentiation inducer along monocyte/macrophage pathway, did not affect HGF release alone but attenuated TPA-stimulated HGF release from the cells, indicating the specific effect of TPA or 1 ,25-(OH)2D,, but not the effect associated with cell differentiation. The data supportive of this hypothesis are that dbcAMP, a granulocyte inducer, also stimulated HGF re- lease from the cells that preceded dbcAMP-induced cell differentiation. This stimulation was also attenuated by 1,25-(OH),D,. It was very likely that TPA, dbcAMP, and 1 ,25-(OH),D3 modulated HGF release from the cells by affecting its synthesis as reflected by both Northern blotting experiment and by a close correlation between extracellular and intracellular HGF levels. Very recently, it was reported that a 28-Kd HGF-immunoreactive peptide is synthesized by various cell lines, human placenta, and fibroblasts from different tissues, which is derived from an alternative human HGF transcript and that this smaller HGF variant, whose transcript is detected as 1.3-kb message, specifically inhibits HGF-induced mitogenesis of B5/589 human mammary epithelial cells.30 However, in HL-60 cells, neither a 28-Kd-immunoreactive peptide nor 1.3-kb HGF RNA species was detected,' thus validating our ELISA system to determine HGF levels in HL-60 cell system." TPA is known to interact with its specific receptor on the plasma membrane,' and recent investigations point to C-kinase as the receptor for TPA.32 With regards to stimulatory action on HGF release, TPA seemed to work through an activation of C-kinase because 20 pmol/L H7 but not HA1004 could completely block TPA-stimulated HGF release from the cells. Injury of the liver, which is known to cause ROS formation, leads to the stimulation of HGF synthesis,6 suggesting ROS formation as a possible stimulus. Because TPA is also known as a stimulator of ROS formation,', we studied the involvement of ROS in TPA-induced HGF synthesis in HL-60 cells. However, TPA seemed not to stimulate HGF release via ROS formation as reflected by the absence of the effect of potassium superoxide or cumene hydroperoxide. HGF, also known as hepatopoietin A, is a heparin-binding heterodimeric protein of 105 Kd, consisting of a heavy and a light chain with an apparent molecular weight of 54 to 65 and 3 1.5 to 34.5 Kd, respectively.6 It was originally identified as a complete mitogen for hepatocytes in primary cultures and plays a physiologic role in liver regeneration.* However, it has no homology with the various known growth factors. It has high homology with plasminogen (38%) and proteins of the blood coagulation cascade provided with 'kringle' motifs, such as tissue-plasminogen activator, urokinase, factor XII, and prothrombin, but deficient of the proteolytic a~tivity.~ Cross-linking experiments showed that HGF binds a protein of the apparent molecular weight of 150 Kd, a size consistent with the molecular weight of the 0 subunit of the e-MET receptor.39 Furthermore, HGF stimulates the phosphorylation on tyrosine of p I90'-"" kinase. 40 Northern blot analysis showed that HGF mRNA is expressed in various rat tissues, including liver, kidney, lung, thymus, and brain.' It has been reported recently that HGF exerts its effect on various kinds of cells such as endothelial cells and melanocytes.' Furthermore, it was shown that HGF is identical with scatter factor, a fibroblast-secreted protein that promotes motility and matrix invasion of epithelial cells." These data strongly suggested an important physiologic role of HGF in the proliferation of a much broader spectrum of cell types than originally considered. Because 1,25-(OH),D, is known to stimulate bone resorption by increasing osteoclast number in bone4' and it affects HGF synthesis in the HL-60 cell system, a relevant system for the investigation of molecular mechanism of 1 ,25-(OH),D, on b~n e ,~~"~. "
we checked the effect of HGF on bone cells. The activities and numbers of osteoclast are known to be intimately regulated by osteoblast, which is responsive to 1 ,25-(OH),D, , 43 as reflected by the presence of 1,25-(OH),D, receptor.44 As shown in Fig 7, HGF stimulated mouse bone cells with osteoblastic phenotype, MC3T3-E 1. Taken collectively, these data raised the possibility that I ,25-(OH),D, might exert its effects on bone at least partly by affecting HGF synthesis.
